The definition of Market Access was first reported by the World Trade Organization as to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade.
Pharmaceutical Market Access is different and it could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology.
By the way, Market Access is not only the marke.